Objective: To assess the predictive ability of a combination of anogenital distance (AGD) and anti-Müllerian hormone (AMH) to diagnosis the presence of endometriosis without surgery.
| INTRODUCTION
Endometriosis is an estrogen-dependent disease defined as the presence of endometrial tissue functionally active outside the uterine cavity.
1 It can damage many organs, but the most frequently affected one is the ovary. There are different types of endometriosis, including endometriotic cysts (endometriomas), deep infiltrating endometriosis (DIE), and superficial implants. 1 Endometriosis has a prevalence of approximately 10%, affecting 4%-30% of women of reproductive age, 2 and is usually associated with infertility. 3 Between 30% and 50%
of women with endometriosis have reproductive problems; this percentage rises to 70%-80% if pelvic pain is present. One of the challenges in endometriosis is its early diagnosis among patients with clinical disease. Standard diagnosis is carried out by direct visualization and examination of histologic lesions; however, histologic samples are not always available and this approach may not be feasible for early stages of the disease or for screening a healthy population. 5 Although several predictive models for diagnosis of endometriosis have been proposed, 6 none of them has been widely applied. In general, the models have been designed for a specific subtype of endometriosis.
7
Circulating anti-Müllerian hormone (AMH) seems to be the best biochemical marker of ovarian function, owing to its ability to reflect the number of antral and pre-antral follicles present in the ovaries. 8 It has been applied to various clinical situations, such as monitoring the response to ovarian stimulation in assisted reproductive techniques, timing of menopause, and iatrogenic damage to the ovarian follicle reserve. 8 It has also been used to assess ovarian reserve depletion after surgery for endometriomas, 9 and as a follow-up biomarker for women with histologically confirmed severe endometriosis (stages III-IV). 10, 11 However, the influence of endometriosis itself on ovarian reserve remains controversial. 9, 12 Anogenital distance (AGD) is thought to be an accurate marker of the prenatal hormonal milieu and potential intra-uterus insults.
A relationship between shorter AGD and the presence of endometriosis, both endometriomas and DIE, has recently been reported 13 supporting the idea that this disease has a potential intrauterine origin. Moreover, AGD has been shown to be a suitable diagnostic tool in endometriosis. 
| MATERIALS AND METHODS
The present study compared data between women with endometriosis and a control group at the Department of Obstetrics and Gynecology, Clinical University Hospital "Virgen de la Arrixaca," Murcia, Spain, The inclusion criterion for the endometriosis group was attendance at the endometriosis unit of the study hospital, including prevalent and incident endometriosis. The exclusion criteria were pregnancy, previous surgery for endometriosis, oncologic treatment, and genitourinary prolapse. Endometriosis was diagnosed by clinical interview and confirmed by symptoms, signs, and transvaginal ultrasonography (TVUS) findings. 15 Endometriosis was further classified as endometriomas or DIE. The control group included women without endometriosis were recruited during routine gynecologic visits. For both groups, consecutive women attending the clinic were recruited.
During the study visit, all participants were interviewed by two gynecologists using an established method. A non-fasting blood sample was drawn between 08:00 and 10:00 on the same day as the clinical appointment, which was selected to coincide with the early follicular phase of the menstrual cycle (days 2-5). Serum concentrations of AMH were measured at the study hospital's laboratory by enzyme-linked immunosorbent assay (Elecsys AMH assays;
Roche Diagnostics, Mannheim, Germany). The intra-and inter-assay coefficients of variation were 3.7% and 2.7%, respectively, and assay sensitivity was 0.01 ng/mL. Recoveries after a 10% dilution of samples and mixing with high and low AMH concentrations ranged from 94% to 103%. The clinical cut-off for normal serum AMH was set at 1 ng/mL.
Analyses were conducted with SPSS version 19.0 (IBM, Armonk, NY, USA). Descriptive statistics were used to report data. Continuous variables were compared by using the unpaired Student t or MannWhitney U test; categoric variables were compared by using χ 2 test.
Unconditional multiple logistic regression was used to explore the relationship between the presence of endometriosis and AGD (below/ above median value) or AMH (below/above clinical cut-off) using odds ratios (ORs) and 95% confidence intervals (CIs). Age, height, weight, BMI, vaginal delivery, and episiotomy were tested as covariates.
Vaginal delivery was included as a covariate because it might distort AGD in women; BMI was included because AGD is an anthropometrydependent measure.
To assess the ability of AGD and AMH to detect endometriosis, receiver operator characteristic (ROC) curves were generated by using maximum likelihood estimation to fit a binomial ROC curve to continuously distributed data. The ROC curves were based on AGD AF measurements, AMH levels, or both variables combined (AMH and AGD AF ), and the presence of all endometriosis or endometriomas versus controls. AGD measurements were dichotomized by using the optimal cut-off point based on the maximum Youden index, and sensitivity, specificity, and positive and negative likelihood ratios were calculated. All statistical tests were two-tailed at a 0.05 significance level.
| RESULTS
During the study period, 57 women with endometriosis (45 with endometriomas and 12 with DIE), and 93 women without this condition were recruited. The women were aged 18-50 years. Overall, women with endometriosis were older (mean ± SD age 36.2 ± 7.6 vs 29.7 ± 5.9 years; P<0.001) and had a higher incidence of vagi- Table 2 ).
An AGD AF measurement below the median value was also associated with endometriosis ( women with AGD AF below the median were 3.72 (95% CI 1.64-8.50) and 2.82 (95% CI 1.23-6.64) times more likely to have endometriosis or endometriomas, respectively, as compared with women with a value above the median.
The accuracy of AMH, AGD AF , and combined AMH and AGD AF to diagnose endometriosis or endometriomas is summarized in Table 4 .
Overall, the area under the curve (AUC) was greater for AMH plus AGD AF than for AMH or AGD AF alone, indicating that AMH plus AGD AF has a stronger predictive value for discriminating both endometriosis overall and the endometriomas subtype. 
| DISCUSSION
The present findings indicate that low levels of AMH (<1 ng/mL) might be used to identify women with endometriosis. Similarly, shorter AGD AF , a biomarker of the intrauterine hormonal environment, might also predict the presence of this condition. To our knowledge, this is the first time that the combined ability of AMH and AGD AF to predict endometriosis has been explored. The diagnostic accuracy of the combined predictive model was better than that of AMH or AGD alone.
Regarding AMH, the present findings are consistent with those of Pacchiarotti et al., 11 who proposed AMH as a biomarker capable of identifying ovarian depletion caused by early ovarian damage in progressive diseases such as endometriosis for women who have not undergone surgery. Other studies have also suggested that endometriomas are associated with a decreased ovarian reserve, which results in lower AMH levels. Chen et al. 17 reported lower mean AMH for women with endometriomas (1.53 ± 1.37 ng/mL) than for women with benign ovarian cysts (2.20 ± 1.23 ng/mL). Moreover, the extent of AMH decline was greater for bilateral endometriomas than for unilateral ones, and no decrease was observed for women in the benign ovarian cyst group compared to endometriosis. Hwu et al. 18 also reported a decrease in AMH among women with endometriomas greater than 3 cm who had not undergone surgery, suggesting a significant reduction of ovarian reserve among these women even before cystectomy.
Kim et al. With regard to AGD, a shorter AGD was recently reported among women with endometriosis, suggesting that these women have been affected by prenatal exposure to an antiandrogenic or estrogenic environment. 13 In addition, AGD AF (but not AGD AC ) was previously found to be associated with the presence of endometriomas, DIE, or both, and was proposed as an efficient tool in predicting the presence of DIE (AUC 0.91, 95% CI 0.84-0.97).
14 The two studies on AGD enrolled women with and without previous surgery in contrast to the present study, which included only women without surgery to avoid the potential effect of surgery on serum AMH levels.
The two markers proposed in the present study, AMH and AGD, are both related to an intrauterine origin of endometriosis; however, there are various hypotheses on the pathogenesis of this disorder. 23 combined clinical markers with plasma CA-125, reporting that levels higher than 35 U/mL were useful in deciding whether a bowel preparation (for suspected DIE) should be administered (sensitivity, 87%; specificity, 83%). Lafay Pillet et al. 24 described a model based on a clinical score of four variables independently associated with DIE that was used to classify patients as being in a low-risk group (score <13), where the probability of DIE was 10% (sensitivity of 95%), or a high-risk group (score >13), where the probability of DIE was 88%
(specificity of 94%). Perelló et al. 7 have described a predictive model for DIE in patients with endometriomas based on one previous pregnancy, past history of surgery for endometriosis, and the mean endometriosis-associated pelvic pain score. The AUC was 0.91 (95% CI 0.86-0.94), the sensitivity of the model was 80%, and the specificity was 84%. Nnoaham et al. 25 produced a model that predicted stage III and IV endometriosis with a sensitivity of 82.3% and specificity of 75.8% based on menstrual dyschezia and a history of benign ovarian cysts. In a study by Eskenazi et al., 26 ovarian endometriosis was accurately predicted by signs, symptoms (infertility, dysmenorrhea, dyspareunia and noncyclic pelvic pain), and TVUS, with excellent agreement with surgical diagnosis. However, only 38% of non-ovarian endometriosis could be predicted using this model. Lastly, Nisenblat et al. 5 reported that TVUS showed relatively high sensitivity (93%) and specificity (96%) in the diagnosis of endometriomas.
The present study has some limitations. First, selection and measurement bias should be considered. However, the control women attended the study hospital in the same period, and were drawn from the same population as the women with endometriosis. Moreover, two gynecologists who were not from the endometriosis unit took the measurements and were unaware of the women's condition. Second, endometriosis was not histologically confirmed; as mentioned above, however, TVUS has relatively high sensitivity (93%) and specificity (96%) for endometriomas 5 and can be used to assess disease status.
Third, owing to the clinical diagnosis used for the current study, misclassification of disease status might have occurred. If present, however, it would have underestimated the value of the true association between AGD and endometriosis. Last, the number of patients was relatively small, potentially limiting the robustness of the results.
In conclusion, the present study has shown that serum AMH levels and AGD AF can be combined in a model to predict endometriosis. As compared with others, this model has advantages because it applies to all types of endometriosis (rather than specific subtypes)
among women who have not undergone surgery. In addition, it does not require previous laparoscopy or TVUS. This might help improve early diagnosis of endometriosis, which in turn would improve patient response to medical or surgical treatments. 27 Because the two markers are obtained by non-invasive techniques, they might be used by general practitioners in the diagnosis of endometriosis. More studies are needed to corroborate the present findings; if confirmed, the combination of AMH levels and AGD might have further clinical implications in the early diagnosis of endometriosis, thereby improving its prognosis.
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